Medicare Enrolled

Dr. Win Kyaw, M.D

Nephrology · Shoreline, WA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1130 N 185TH ST, Shoreline, WA 98133
2065421000
In practice since 2008 (18 years)
NPI: 1700049236 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kyaw from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kyaw? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kyaw

Dr. Win Kyaw is a nephrology specialist in Shoreline, WA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Kyaw performed 1,105 Medicare services across 487 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kyaw received a total of $7,719 from 54 pharmaceutical and/or device companies across 351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kyaw is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 40% volume in WA $7,719 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,105
Medicare services
Top 40% in WA for nephrology
487
Unique beneficiaries
$145
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~61 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
315 $65 $131
Dialysis services for patients 20 or older
Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month.
216 $292 $500
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
215 $95 $185
Dialysis services for adults, 2-3 visits per month
This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month.
119 $243 $375
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
91 $138 $367
Hemodialysis, single evaluation
A dialysis procedure to filter waste from the blood, performed with a physician's evaluation.
57 $59 $174
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
47 $96 $189
Monthly dialysis physician visit
A monthly doctor's visit for patients aged 20 or older who are receiving dialysis treatment.
29 $167 $275
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
16 $138 $240
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,719
Total received (2018-2024)
Avg $1,103/year across 7 years
Top 8% in WA for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
351
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,629 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,452
2023
$1,032
2022
$1,097
2021
$1,038
2020
$823
2019
$1,110
2018
$1,168

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$244
Novartis Pharmaceuticals Corporation
$178
AstraZeneca Pharmaceuticals LP
$140
Ardelyx, Inc.
$125
Boehringer Ingelheim Pharmaceuticals, Inc.
$102
Alexion Pharmaceuticals, Inc.
$83
Bayer Healthcare Pharmaceuticals Inc.
$72
Ascensia Diabetes Care Us Inc.
$62
Dexcom, Inc.
$55
Novo Nordisk Inc
$46
RECORDATI_RARE_DISEASES_INC.
$43
GlaxoSmithKline, LLC.
$42
Otsuka America Pharmaceutical, Inc.
$29
Aurinia Pharma U.S., Inc.
$28
Travere Therapeutics, Inc.
$28
Kyowa Kirin, Inc.
$25
Insulet Corporation
$24
Tandem Diabetes Care, Inc.
$23
Mannkind Corporation
$21
CALLIDITAS THERAPEUTICS US INC.
$21
GENZYME CORPORATION
$21
CorMedix Inc.
$20
Xeris Pharmaceuticals, Inc.
$20
Top 3 companies account for 38.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$886
Amgen Inc.
$646
Otsuka America Pharmaceutical, Inc.
$626
Relypsa, Inc.
$434
Novo Nordisk Inc
$359
GlaxoSmithKline, LLC.
$350
Novartis Pharmaceuticals Corporation
$339
Horizon Therapeutics plc
$331
Janssen Pharmaceuticals, Inc
$246
Boehringer Ingelheim Pharmaceuticals, Inc.
$221
Aurinia Pharma U.S., Inc.
$208
Travere Therapeutics, Inc.
$193
Lilly USA, LLC
$162
Ardelyx, Inc.
$148
Alexion Pharmaceuticals, Inc.
$139
Radius Health, Inc.
$136
GENZYME CORPORATION
$130
SANOFI-AVENTIS U.S. LLC
$130
Amarin Pharma Inc.
$126
Abbott Laboratories
$124
Xeris Pharmaceuticals, Inc.
$121
Bayer HealthCare Pharmaceuticals Inc.
$121
Bayer Healthcare Pharmaceuticals Inc.
$114
Takeda Pharmaceuticals U.S.A., Inc.
$106
OPKO Pharmaceuticals, LLC
$94
AKEBIA THERAPEUTICS INC
$87
Vifor Pharma, Inc.
$81
RECORDATI_RARE_DISEASES_INC.
$80
Corcept Therapeutics
$75
Kyowa Kirin, Inc.
$70
Ascensia Diabetes Care Us Inc.
$62
AMAG Pharmaceuticals, Inc.
$58
Dexcom, Inc.
$55
Medtronic, Inc.
$50
Shire North American Group Inc
$48
Tandem Diabetes Care, Inc.
$47
Horizon Pharma plc
$45
Mannkind Corporation
$43
Genentech USA, Inc.
$42
Calliditas Therapeutics US Inc.
$40
Merck Sharp & Dohme Corporation
$38
Kowa Pharmaceuticals America, Inc.
$38
Fisher Scientific Company L.L.C.
$35
CeQur Corporation
$28
Ascensia Diabetes Care US Inc.
$25
MannKind Corporation
$25
Ascendis Pharma Inc
$24
Insulet Corporation
$24
Medtronic MiniMed, Inc.
$21
CALLIDITAS THERAPEUTICS US INC.
$21
CorMedix Inc.
$20
Otsuka Pharmaceutical Development & Commercialization, Inc.
$17
Bigfoot Biomedical Inc
$16
Regeneron Healthcare Solutions, Inc.
$15
Top 3 companies account for 28.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AURYXIA · Auryxia · BENLYSTA · CYSTADROPS · CeQur Simplicity · Contour Next · Crysvita · DefenCath · Dexcom G6 Transmitter · ELLIPSYS VASCULAR ACCESS SYSTEM · ENTRESTO · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · FABRAZYME · FARXIGA · FERAHEME · FreeStyle Libre · GATTEX · GVOKE HYPOPEN · GVOKE PFS · IBSRELA · INVOKANA · InPen · JARDIANCE · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kerendia · Korlym · LOKELMA · LUPKYNIS · LYUMJEV · Livalo · MOUNJARO · Minimed 670G System · NATPARA · Omnipod · Ozempic · PRALUENT ALIROCUMAB INJECTION · Parsabiv · Procalcitonin · RAYALDEE · RECORLEV · RYBELSUS · Rayaldee · Repatha · Rituxan · Rybelsus · SAMSCA · SIGNIFOR LAR · SOLIQUA 100/33 · SOLIRIS · STRENSIQ · TARPEYO · TAVNEOS · TEPEZZA · TOUJEO · TRULICITY · Tavneos · Tymlos · ULTOMIRIS · UNITY DIABETES MANAGEMENT SYSTEM · Uloric · Vascepa · Veltassa · Wegovy · XARELTO · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for nephrology in WA.

Looking for a nephrology specialist in Shoreline?
Compare nephrologists in the Shoreline area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
112
Per 100K population
4.9
County median income
$122,148
Nearest hospital
SEATTLE CHILDREN'S HOSPITAL
6.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kyaw is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 8% of WA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kyaw experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Kyaw performed 315 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kyaw receive payments from pharmaceutical companies?
Yes. Dr. Kyaw received a total of $7,719 from 54 companies across 351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kyaw's costs compare to other nephrologists in Shoreline?
Dr. Kyaw's average Medicare payment per service is $145. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kyaw) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →